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Received 24 April 2010; received in revised form 24 August 2010; accepted 26 August 2010Abstract The therapeutic potential of human embryonic stem cells (hESCs) has long been appreciated, and the recent FDA
approval of hESC derivatives for cell-based therapy encourages the clinical application of hESCs. Here, using CHA3-hESCs with
normal and abnormal karyotypes, we report the importance of maintaining normal chromosomes during in vitro culture and the
differentiation of hESCs for minimization of posttransplantation complications. We found that undifferentiated CHA3-hESCs
with trisomy chromosome 12 undergo abnormal cell division with multiple spindles in comparison to the bipolar cell division of
the karyotypically normal CHA3-hESCs. Transplanted karyotypically abnormal CHA3-hESC derivatives formed a tumor-like tissue
6 weeks after transplantation in two out of seven mice tested. Our results demonstrate that the preservation of normal
chromosomes is indispensable for maintaining the true properties of hESCs in vitro and abolishing adverse effects
posttransplantation. Thus, the development of optimized techniques for stabilizing the chromosome state during in vitro
hESC culture is a prerequisite for the therapeutic application of hESCs.
© 2010 Elsevier B.V. All rights reserved.Introduction
Human embryonic stem cells (hESCs) have been widely
regarded as a new cell source for regenerative therapy of
currently untreatable human diseases (Thomson et al.,⁎ Corresponding author. CHA University and CHA Bio & Diostech
Co., Ltd., 605-21 Yeoksam-1 dong, Gangnam gu, Seoul 135-907,
Korea.
E-mail address: stemchung@gmail.com (H.-M. Chung).
1873-5061/$ – see front matter © 2010 Elsevier B.V. All rights reserved
doi:10.1016/j.scr.2010.08.0061998). However, their prolonged culture in vitro is subject
to chromosomal instability (Buzzard et al., 2004; Yang et al.,
2008a), especially numerous changes in chromosomes 12 and
17, which presents a challenge to the safe therapeutic
application of hESCs as they have potential for tumor
progression (Clark et al., 2004; Draper et al., 2004).
Chromosomal instability is a phenomenon that indicates an
increased rate of numerous changes of whole chromosomes.
It is a hallmark of many tumors (Lengauer et al., 1997;
D'Assoro et al., 2002; Nigg, 2002; Sluder and Nordberg, 2004)
and is generated by the presence of extra centrosomes that
promote multipolar anaphase, giving rise to multiple
aneuploid daughter cells with proliferative advantages,.
51Effect of chromosome instabilitymetastatic potential, or chemoresistance (Gao et al., 2007;
Nowell, 1976; Ganem et al., 2009; Rajagopalan and
Lengauer, 2004; Weaver et al., 2007).
In this study, we emphasize the importance of sustaining
normal human chromosomes during in vitro culture and
differentiation for safe transplantation of derivatives. By
observing the aberrant cell division of karyotypically
abnormal hESCs using confocal microscopy, we provide
supporting evidence that chromosomes are unstable during
in vitro culture. In addition, to compare in vivo survival and
chromosome stability of hESC-derived cell types after
transplantation, a chimney was positioned on the periph-
eral site of a surgically wounded mouse model transplanted
with endothelial cells derived from red fluorescence
protein (RFP)-transfected normal and abnormal hESCs
(Levenberg et al., 2002; Cho et al., 2007; Kim et al.,
2007a). A 6-week, long-term follow-up study showed that
the derivatives of normal RFP-hESCs survived and carried
normal human chromosomes. However, when derivatives
from abnormal hESCs were transplanted, they formed a
tumor-like tissue after 6 weeks of implantation in two out
of the seven mice tested. Our results show that hESC
chromosomes are unstable during in vitro culture and
normal chromosome status is indispensable for safe
transplantation of their derivatives for therapeutic use.Results
Genetic alteration of hESCs and their characteristics
In this study, we used our established CHA3-hESCs (Fig. 1A)
(Cho et al., 2007), which have a normal chromosome
number, i.e., 44+XY (Fig. 1B). To characterize the hESCs in
vitro, we examined the expression of a pluripotency marker,
Oct-4, by immunocytochemistry (Figs. 1A and C). Next, to
investigate the pluripotent potential of the hESCs in vivo, we
injected the undifferentiated CHA3-hESCs (3×105 cells) into
the dorsal region of NOD/SCID mice and euthanized the mice
12 weeks later. Histological analysis showed tissues repre-
senting all three germ layers in the teratomas extracted from
the mice by immunohistochemistry (Figs. 1D–G). From these
results, we concluded that the CHA3-hESC line possessed
general hESC characteristics in vitro and in vivo.
During normal CHA3-hESC culture (Fig. 1A), we discovered
that trisomy of chromosome 12 had occurred in CHA3-hESCs
(Fig. 1H), among the cultured cells under normal hESC culture
conditions. It has been reported that cultured hESCs are prone
to karyotypic instability during extensive in vitro proliferation
and, consequently, undergo cell division reminiscent of cancer
cells (Draper et al., 2004; Baker et al., 2007). To examine this
possibility, we performed immunocytochemistry on karyotyp-
ically normal (Fig. 1B) and abnormal (Fig. 1H, trisomy of
chromosome 12) CHA3-hESCs using antibodies against an
undifferentiated (Oct-4) and spindle marker (α-tubulin) phe-
notype. As a result, we observed that euploid hESCs underwent
symmetrical cell division with bipolar spindles (Fig. 1C), but
aneuploid cells, which acquired an extra chromosome12 during
in vitroproliferation, abnormally dividedwithmultiple spindles
(Fig. 1I). To further investigate the pluripotent potential of the
abnormal hESCs in vivo, we injected the undifferentiated
CHA3-hESCs with trisomy of chromosome 12 (3×105 cells) intothe dorsal region of NOD/SCID mice and euthanized the mice
12 weeks later. The sizes of the formed teratomas were similar
to those in the normal chromosome group (data not shown); in
addition, histological analysis by immunohistochemistry
revealed tissues representing all three germ layers in the
teratomas extracted from mice (Figs. 1J–M). From these
results,we suggested that even though karyotypically abnormal
(trisomy of chromosome 12), CHA3-hESCs aberrantly divided
with multiple spindles reminiscent of cancer cells, their
proliferative properties, but not their pluripotent potential,
were affected by the extra copy of chromosome 12.
Endothelial cell differentiation capacity of normal
and abnormal CHA3-hESCs
To compare the differentiation potentials of normal and
abnormal CHA3-hESCs, we induced endothelial cell differ-
entiation from normal and abnormal hESCs using hEB
formation as previously described (Cho et al., 2007; Kim
et al., 2007b) (Fig. 2A). Immunocytochemical analysis
showed that the expression pattern of PECAM, an endo-
thelial cell-specific marker, first appeared at the central
region of differentiated hEBs (Fig. 2A, hEB formation stage)
and was continuously expressed at the central region of
attached hEBs (Figs. 2B–D). The well-known neuronal
marker, TuJ1 were used to label ectodermal lineage cells
that first appeared near the surface of hEBs (data not
shown) and were continuously expressed at the surface and
outgrowth regions of attached hEBs (Figs. 2C and D). The
magnified image presented in the red box of Fig. 2C shows
that these PECAM and TuJ1-expressing cells were distin-
guishable (Fig. 2E), and different positions of these two
markers were observed in the z-axis image shown in Fig. 2E
(Fig. 2F). Next, to enrich for populations of endothelial
cells in the attached condition, we supplemented the
DMEM medium containing 10% FBS with VEGF (Bernatchez
et al., 1999; Wang et al., 2007; Yang et al., 2008b) for
induction of endothelial cells after plating the hEBs. After
3 days of VEGF treatment, the number of PECAM-expres-
sing cells dramatically increased compared to the culture
without VEGF (Figs. 2B–F), and many tubule-like structures
formed by PECAM-positive cells were observed under the
VEGF-treated conditions (Fig. 2G) compared to without
VEGF (Fig. 2E). Additionally, PECAM expression was no
longer restricted to the clusters but migrated toward the
peripheral outgrowth region where TuJ1-positive neuronal
cells were localized (Fig. 2H). These data show that VEGF
treatment enriches for PECAM-positive cells and induces
cell differentiation by changing the normal differentiation
pattern. Taken together, although CHA3-hESCs with triso-
my of chromosome 12 could have an abnormal proliferative
property through aberrant cell division, their ability to
differentiate into endothelial cells was unaffected when
compared to karyotypically normal CHA3-hESCs.
Generation of RFP-hESCs and their ability to
differentiate into endothelial cells
To examine the chromosome stability and proliferation poten-
tial of normal or abnormal CHA3-hESCs derivatives post
transplantation in vivo, we transfected hESCs with mRFP using
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Figure 1 CHA3-hESCs with normal or abnormal chromosomes and their cell division. (A) Pluripotency of undifferentiated CHA3-hESCs.
(B) CHA3-hESCs with normal chromosomes, and (C) their cell division with bipolar spindles. (D–G, 40×) Analysis of all three germ layers for
teratomas derived from hESCs with normal chromosomes. (H) CHA3-hESCs with trisomy of chromosome 12, and (I) their cell division with
multiple spindles. (J–M, 40×) Analysis of all three germ layers for teratomas derived from hESCs with abnormal chromosome.
52 S.-H. Moon et al.lentivirus to visualize the fate of implanted cells using Xenogeny
equipment (Fig. 3A) (van der Bogt et al., 2006; Cao et al., 2008;
Ilagan et al., 2006). First, hESCs harboring RFP (Fig. 3B) weregenerated using our previously described technique (Kim et al.,
2007a) and spontaneously differentiated via EB formation
(Fig. 3C). Endothelial cells derived from hESCs (Fig. 3D) were
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Figure 2 Endothelial cell differentiation from normal or abnormal CHA3-hESCs. (A) Strategy employed for endothelial cell
differentiation from hESCs. (B, 40×) Morphology of attached hEB on gelatin-coated plates at Day 5 postplating. (C and D) The
expression patterns of the endothelial cell marker PECAM and the neuronal cell marker TuJ1 are shown in the black box in panel A.
(E) Distinguishable PECAM- and TuJ1-expressing cells are shown in the magnified image in panel C, and (F) their different localizations
are evident in the z-axis image in panel E. (G) Enrichment for endothelial cell populations, and (H) changes in the PECAM expression
pattern following treatment with VEGF.
53Effect of chromosome instabilityFACS-sorted as previously described (Fig. 2A and Supplementary
Fig. 1) (Levenberg et al., 2002; Cho et al., 2007), and we
confirmed the persistent expression of RFP in the differentiated
cells (Fig. 3D). Next, to investigate the chromosome stability
during endothelial cell differentiation of undifferentiated RFP-
expressing hESCs, we analyzed the karyotype of hESC-ECs
derived from undifferentiated normal or abnormal hESCs,
respectively. Chromosomal alterations were not detected
between undifferentiated hESCs and their derivatives in our
differentiation system in vitro (Figs. 3E and F).The fate of hESC derivatives carrying normal or
abnormal chromosomes after in vivo transplantation
After confirmation of chromosome stability during the differ-
entiation of RFP-expressing hESC-ECs derived from normal or
abnormal hESCs in vitro, we first analyzed the chromosome
stability and survival potential of RFP-expressing hESC-ECs
carrying a normal chromosome in a newly developed mouse
wound model with a custom-designed polypropylene circularring (Figs. 4A–C) by Xenogeny. At 6 weeks postimplantation, the
cells still expressed the RFP signal robustly as compared to the
PBS group (Figs. 4D andE). Toprecisely confirmwhether theRFP
signals were expressed by the surviving cells, we isolated the
cells within the circular ring and cultured them on tissue culture
plates in vitro. We found that the isolated cells expressed RFP
(Fig. 4E, white arrowhead). Next, to assess whether RFP-
positive cells were of human origin and carried normal human
chromosomes, we performed karyotypic analysis on the isolated
RFP-positive cells by FACS sorting and confirmed that they had
normal human chromosomes (Fig. 4E).
However, when RFP-hESC-ECs carrying a trisomy of chromo-
some 12 were implanted in this model, a tumor-like tissue was
formed after 6 weeks of implantation in two out of the seven
mice tested (Fig. 5A). When the tissue was prepared for
immunohistochemistry with hematoxylin and eosin (H&E) and
special staining methods, the results did not show the presence
of all three germ layers, in contrast to the results shown in Fig. 1
(Figs. 5B–E), but the proliferation of many cells in a tumor-like
tissue was observed by H&E staining (Fig. 5B). In addition, when
the cells from the tissue were cultured in vitro, they
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Figure 3 Endothelial cell differentiation from RFP-transfected hESCs. (A) mRFP lentiviral vector construct. (B) hESCs harboring RFP
spontaneously differentiated via (C) EB formation and (D) endothelial cells expressing RFP derived from hESCs. (E and F) Karyotypic
analysis of normal or abnormal hESC-ECs.
54 S.-H. Moon et al.demonstrated a faster proliferation rate (Supplementary
Fig. 2A) and morphologically homogeneous cell types (Fig. 5F).
However, they showed the low invasion potential comparison
with endothelial progenitor cells and normal hESC-ECs (Supple-
mentary Fig. 2B) (Cross et al., 1994); in addition, themajority of
the cells expressed RFP (Fig. 5G). RFP-expressing cells were
sorted by FACS and subjected to karyotypic analysis, which
revealed abnormalities in various chromosomes (Figs. 5H and I).
These data indicate that the ability to sustain normal chromo-
somes during the maintenance and differentiation of hESCs is
important for cell therapy using hESC derivatives.Discussion
Controlling the chromosome stability of hESCs and their
derivatives remains a fundamental challenge in trials of hESC
derivative-based cell therapy. In 2004, Andrew and co-workers
reported that chromosomal instability during extensive hESC
expansion was due to the adaptation status of hESCs during invitro culture (Draper et al., 2004). In particular, chromosomal
aberrations have been frequently reported for chromosomes 12
and 17, and this phenomenon was thought to lead to tumor
progression (Yang et al., 2008a). In this present study, we
compared and examined abnormal cell division with multipolar
spindles during aneuploid hESC cell division in in vitro culture.
We confirmed that hESCs carrying a trisomy of chromosome 12
underwent aberrant cell division with multiple spindles (Fig. 1I)
and provided clear evidence that cells with an aberrant
chromosome 12 propagated similarly to cancer-like cells (Sluder
et al., 1997; Chen and Horwitz, 2002; Brinkley and Goepfert,
1998). The common occurrence of changes in chromosome 12
during in vitro culture conditions indicates that if the condition
is notmonitored closely, hESCs can easily become cancer-like or
embryonic carcinoma cells (Draper et al., 2004; Gertow et al.,
2007). Thus, it is critical to examine the cause of the
chromosome instability and develop optimized culture
techniques.
Figure 2A (hEB formation) shows that PECAM-expressing cells
within hEBs derived from abnormal hESCs were similar to our
11 mm
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Figure 4 Newly developed wound model and transplantation of normal hESC-ECs. (A) A full-thickness excisional wound model. (B) Custom-designed polypropylene circular ring. (C) Cell
transplantation with Matrigel within the circular ring of the wound region. (D) Analysis of RFP expression in the wound region using Xenogen 6 weeks after cell transplantation. (E) Survival
potential of RFP-expressing cells within the circular ring in vitro, and karyotypic analysis of isolated RFP-expressing cells by FACS sorting. 55
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Figure 5 The fate of hESCs derivatives carrying abnormal
chromosomes after in vivo transplantation. (A) Tumor-like tissue
formation from transplanted RFP-hESC-ECs carrying a trisomy of
chromosome 12 at 6 weeks posttransplantation. (B–E, 100×)
Immunohistochemical analysis of tumor-like tissue using H&E
and special staining. (F) Morphology and (G) RFP expression of
cells isolated from the tumor-like tissue. (H and I) Karyotypic
analysis of cells isolated from the tumor-like tissues 6 weeks
after implantation in two out of the seven mice tested.
56 S.-H. Moon et al.previous work which has demonstrated that PECAM-positive
cells are localized in the center of normal hEBs (Cho et al., 2007;
Kim et al., 2007b). Chromosome instability with trisomy of
chromosome 12 affects the proliferative potential of undiffer-
entiated hESCs in culture but does not influence them during
endothelial cell differentiation in the present study.
Finally, we assessed the survival of karyotypically normal
and abnormal hESC derivatives in vivo and their potential to
undergo chromosomal changes after transplantation. Nu-
merous researchers have transplanted hESC derivatives in
animal models and confirmed their survival and functionality
in vivo (Cho et al., 2007; Laflamme et al., 2007; Lu et al.,
2007), but the potential chromosomal changes of the donor
cells in vivo have not been studied. In addition, many
researchers have attempted to analyze in vivo cell survival
using cell tracking (Brazelton and Blau, 2005), molecular
imaging (van der Bogt et al., 2006), and gene transfection (Li
et al., 2008) but have failed to provide accurate results
(Swenson et al., 2007; Pawelczyk et al., 2008). To overcome
the above-noted problems, we established RFP-hESCs (Fig. 3)
using a lentivirus system and produced a new animal model
with a wound using a PE chimney for observation of
transplanted cells (Fig. 4). Using our developed system
together with techniques such as RFP transfection, euploid
and aneuploid hESCs carrying a trisomy of chromosome 12
were induced to differentiate and analyzed for 6 weeks after
transplantation into an animal model. Transplanted euploid
hESC derivatives maintained normal human chromosome
numbers, but aneuploid hESC derivatives continued to
undergo further chromosomal changes in two among the
seven mice tested. These results demonstrate the impor-
tance of maintaining normal human chromosomes prior to
transplantation; the safety of hESC derivatives carrying
normal human chromosomes is improved compared with
those carrying abnormal chromosomes.
In summary, we first discovered that the chromosome
instability with trisomy of chromosome 12 in hESCs caused
them to divide with multiple spindles and increased the
proliferative potential of undifferentiated hESCs but did not
affect the differentiation of endothelial cells. Second, we
found that the chromosome instability of hESC derivatives
gave rise to a tumor-like tissue in vivo in the absence of
teratomas, using RFP-hESCs and a newly developed wound
model to analyze the fate of injected hESCs derivatives.
Thus, our approach used to assess the importance of
chromosome stability in hESCs revealed that the chromo-
some instability of hESCs with trisomy of chromosome 12
during maintenance changed the proliferative potential of
hESCs via cell division with multiple spindles in vitro and
their derivatives, which formed a tumor-like tissue in vivo.
Based on these results, we suggest that optimized culture
techniques that sustain the chromosome stability of hESCs
should be required for clinical trials using hESC derivatives.
Materials and methods
hESC culture, hEB formation, and differentiation
into endothelial cells
Undifferentiated hESCs (CHA3-hESC line) were grown on
mitotically inactivated MEF cells in DMEM/F12 (50:50%;
57Effect of chromosome instabilityGibco BRL, Gaithersburg, MD) supplemented with 20% (v/v)
serum replacement (Gibco) and basic ES medium compo-
nents including 1 mM L-glutamine (Gibco), 1% nonessential
amino acids (Gibco), 100 mM beta-mercaptoethanol (Gibco),
and 4 ng/mL bFGF (Invitrogen, Grand Island, NY). The
medium was changed every 24 h, and the hESCs were
transferred to new feeder cells every 5–7 days with dissect-
ing pipettes. For EB formation, hESCs were detached from
the feeder cells with dispase (Gibco), transferred to Petri
dishes, and then suspended in bFGF-free hESC culture
medium for 7 days (Cho et al., 2007; Kim et al., 2007b). To
differentiate hESCs into endothelial cells, hEBs were split
onto a 0.1% gelatin-coated plate and cultured in DMEM
medium supplemented with 10% FBS (Gibco) for 5 days.
Subsequently, to enrich for attached cells, the medium was
replaced with DMEM supplemented with 10% FBS and 20 ng/
ml VEGF medium for 5 days. To isolate endothelial cells from
hESC derivatives, cell sorting using FITC-conjugated mouse
anti-human monoclonal PECAM antibody (BD Biosciences,
Bedford, MA) was performed with a FACS Vantage flow
cytometer (BD Biosciences) (Levenberg et al., 2002)
(Fig. 2A). The sorted cells were cultured in EGM-2MV
(Clonetics, San Diego, CA).mRFP lentiviral vector construct and
virus production
The lentiviral vector construct (CSII-EF-mRFP1) used in our
study was donated by Dr. Hiroyuki Miyoshi. The construct
contains common domains such as a central polypurine tract,
central termination sequence, promoter region, and wood-
chuck hepatitis virus (Fig. 3A). The human immunodeficiency
virus type 1 expressing the mRFP gene was produced by
transient transfection into 293 T cells. Briefly, about 70%
confluent 293 T cells in a 15-cm dish were transfected using
the calcium phosphate transfection buffer with plasmid DNA:
the envelope plasmid pRSV-REV harboring the gene encoding
VSV-G, the packaging plasmid pCAG-HIVgp, and the transfer
vector. The medium was replaced after 12 to 16 h with DMEM
(Gibco) supplemented with 10% FBS. The medium containing
the viral particles was collected 48 h after transfection and
filtered through 0.45-nm filters. Virus was concentrated at
50 000 g at 4 °C for 4 h. Viral titers (TU/ml) were determined
by transfection of 293 T cells with serial dilutions of the viral
supernatant and FACS analysis of the percentage of mRFP-
expressing cells. Titers of the concentrated lentiviral vector
ranged from 1 to 2×108 transducing units per milliliter.Transfection of hESCs with mRFP virus particles
Before transfection, hESCs were trypsinized and plated onto
BD Matrigel hESC-qualified matrix-coated culture dishes. The
hESCs were transfected after 24 h of plating with medium
containing viral particles by incubating for 10 h. After 10 h,
the hESCs were washed with culture medium and continu-
ously cultured. Next, RFP-expressing cells were sorted using
a FACSVantage flow cytometer. The sorted cells were
cultured in bFGF-containing hESC culture medium (Kim et
al., 2007a; Braam et al., 2008) (Fig. 3B).Karyotype analysis
Chromosome analysis was performed according to standard
methods with minor modifications (Dutrillaux and Viegas-
Pequignot, 1981). Three days after replating, hESCs were
incubated with 100 μl of colcemid (Gibco) for 3 h at 37 °C in a
CO2 incubator and then detached by 0.25% trypsin-EDTA.
After treatment with a hypotonic solution (1% citrate
buffer), lysed cells were fixed in fixation solution (ethanol:
glacial acetic acid at 3:1). G-banding was observed for
identification of chromosomes. Karyotype analysis was
performed at a genetic analysis laboratory in CHA General
Hospital (Kim et al., 2007a).
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde and permeabi-
lized with 0.1% Triton X-100 in PBS (Gibco) for 5 min. After
treatment with 1% normal goat serum for 30 min, the cells
were incubated with Oct-4 (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA), Tra-1-60, TuJ1, α-tubulin (Abcam Inc.,
Cambridge, MA), and PECAM (Millipore) antibodies for 12 h at
4 °C. Cells were washed with PBS and then incubated with
rhodamine-conjugated or FITC-conjugated secondary anti-
bodies (Molecular Probes Inc., Eugene, OR) for 1 h. The
stained slides were mounted with a glycerol-based mounting
solution containing 2.5% polyvinyl alcohol and 1,4-diazabi-
cyclooctane with DAPI (Sigma). All images were analyzed
with a LSM 510 META confocal microscope (Carl Zeiss Inc.,
Oberkochen, Germany).
Animal model and in vivo fluorescence imaging
All animals were cared for humanely in compliance with the
Guide for the Care and Use of Laboratory Animals published
by the National Institutes of Health (National Institutes of
Health publication No. 85-23, revised 1996). Male athymic
nude mice (Jungang Laboratory Animal, Seoul, Korea), aged
6 weeks and weighing 25 to 30 g, were anesthetized by
intraperitoneal injection of 100 μl of a solution containing
xylazine (20 mg/kg) and ketamine (100 mg/kg). After the
dorsal surface of each mouse had been disinfected with an
alcohol swab, a full-thickness excisional wound (1.2 cm in
diameter) was created on the dorsal-medial back of each
animal, using a standard skin biopsy punch (Acuderm Inc.,
Fort Lauderdale, FL). Immediately after surgery, wounds
were fixed by insertion of a custom-designed polypropylene
circular ring (inner diameter 11 mm). The wound in the ring
was covered with 3×105 PECAM-expressing cells from normal
or abnormal CHA3-hESC derivatives or a PBS mixture, with
growth factor reduced BD Matrigel to reduce cell migration
within the transplanted region. Finally, the wound was
covered with transparent film (Opsite, Smith & Nephew)
placed on the top of the polypropylene ring to prevent
leaking and drying. Three experimental groups of male
athymic nude mice were established in this study: a sham-
operated group with untreated wounds (control), wounds
treated with normal chromosome hESC-derived PECAM-
expressing cells, or abnormal chromosome hESC-derived
PECAM-expressing cells. Each group underwent experiments
to evaluate all wounds for 6 weeks postsurgery (n=7 for each
58 S.-H. Moon et al.group). In vivo fluorescence images of RFP-expressing,
PECAM-expressing cell-transplanted mice were observed
using a Xenogen IVIS imaging system (Xenogen Corp.,
Alameda, CA).
Teratoma formation and
immunohistochemical analyses
Undifferentiated hESCs (3×105) were injected into the
dorsal region of 6-week-old, nonobese, diabetic/severe
combined immunodeficiency (NOD/SCID) mice (The Jackson
Laboratory, Bar Harbor, ME). The resulting teratomas were
removed 12 weeks later. Samples from the teratomas were
paraffin-embedded and serially sectioned (5 μm) using a
microtome (Leica Microsystems, Wetzlar, Germany). To
analyze the three germ-layer lineage cells derived from
injected hESCs in the teratomas, sectioned slides were
histologically examined by hematoxylin and eosin for the gut
epithelium and special stains as follows: PAS stain for the
secretory epithelium, Alcian blue stain for cartilage, and
Masson's trichrome stain for muscle fibers. Images were
analyzed using an inverted microscope system (Nikon).
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.scr.2010.08.006.Acknowledgment
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